Skip to content

CorMedix CRMD Price / sales

Price / sales at other companies

Pfizer logo
PfizerPFE
2.5×+0.2×
Merck & Co. logo
Merck & Co.MRK
4.5×+1.0×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.7×-1.8×
ITG
Integer HoldingsITGR
1.6×-0.7×
IAR
Integra LifeSciencesIART
0.4×-0.6×
MiMedx Group logo
MiMedx GroupMDXG
1.5×-1.7×

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

Based on the most recent quarter.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's price / sales?
CorMedix (CRMD) reported price / sales of 1.3× in Q1 2026.
How has CorMedix's price / sales changed year-over-year?
CorMedix's price / sales decreased by 72.4% year-over-year, from 4.9× to 1.3×.
What is the long-term trend for CorMedix's price / sales?
Over 4 years (2020 to 2025), CorMedix's price / sales has grown at a -77.7% compound annual growth rate (CAGR), from 1,182.9× to 2.9×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.